Oracle Healthcare Acquisition Corp.'s common stock has been deleted from OTC Bulletin Board effective May 9, 2008 under the 34 Act. Its been moved to Moved to the Other OTC.

Oracle Healthcare Acquisition Corp. announced its stockholders voted to approve the dissolution of the Company and its proposed plan of liquidation, as presented in the Company's proxy statement dated April 16, 2008, at the special meeting of stockholders held on May 7, 2008. As previously announced, the Company has set May 7, 2008 as the record date for determining the stockholders entitled to receive a liquidating distribution, if any, from the trust account in which the proceeds from the Company's initial public offering were placed and the Company expects to pay the liquidating distribution, if any, on or around May 12, 2008. The Company has filed a certificate of dissolution with the Secretary of State of the State of Delaware for the purpose of affecting its dissolution and has filed a Certificate of Termination of Registration on Form 15 with the Securities and Exchange Commission for the purpose of deregistering its securities under the Securities Exchange Act of 1934, as amended. As a result, the Company will no longer be a public reporting company and its securities will cease trading on the OTC Bulletin Board. The Company filed a definitive proxy statement with the U.S. Securities and Exchange Commission (SEC) on Schedule 14A on April 16, 2008 regarding the dissolution and Plan of Liquidation of the Company. Stockholders and investors are encouraged to read the definitive proxy statement because it contains important information regarding the dissolution and Plan of Liquidation of the Company.

Oracle Healthcare Acquisition Corp., Special/Extraordinary Shareholders Meeting, May 07, 2008, at 10:00 US Eastern Time. Location: Willkie Farr & Gallagher LLP, 787 Seventh Avenue, New York, NY 10019,United States. Agenda: To approve the dissolution of the company and the proposed Plan of Liquidation in, or substantially in, the form of Annex A to the accompanying proxy statement; and to authorize the company's Board of Directors or its Chairman, in their discretion, to adjourn or postpone the special meeting for further solicitation of proxies, if there are not sufficient votes at the originally scheduled time of the special meeting to approve the foregoing proposal.